Laverock Therapeutics

BiotechnologySeedLondon, UKlaverocktx.com

Latest round

Seed

Last raised

Jun 2025

Total raised

$26M

Investors

10

About Laverock Therapeutics

Based in London, UK, and founded in 2021, Laverock Therapeutics, formerly known as Skylark Therapeutics Limited, operates as a developer of gene silencing systems to create programmable cell therapies for the next generation. The company offers various gene editing solutions that include Gene Editing induced Gene Silencing (GEiGS®) used for gene editing tools offering gene editing workflows and assessment of off-target profiles. The company also provides a bioinformatics platform that uses GEiGS® technology for the development of allogeneic adoptive cell treatments targeting specific endogenous or exogenous genes.

Who invested in Laverock Therapeutics

10 investors across 2 rounds

See all investors in Laverock Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jun 1, 2025

    Amount

    $8.8M

    Investors

    Locked

  2. Seed

    Sep 18, 2023

    Amount

    $17M

    Investors

    Locked

Questions about Laverock Therapeutics

Who invested in Laverock Therapeutics?

Laverock Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Laverock Therapeutics raised?

Laverock Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Laverock Therapeutics last raise money?

Laverock Therapeutics's most recent round on record is a Seed, in Jun 2025.

What does Laverock Therapeutics do?

Based in London, UK, and founded in 2021, Laverock Therapeutics, formerly known as Skylark Therapeutics Limited, operates as a developer of gene silencing systems to create programmable cell therapies for the next generation.

Where is Laverock Therapeutics headquartered?

Laverock Therapeutics is headquartered in London, UK.

Which VCs invest in companies like Laverock Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Laverock Therapeutics's stage. Their profiles are linked below.

Raising like Laverock Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.